Literature DB >> 16913899

Guidelines for the management of community acquired pneumonia in adults, revised edition.

.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16913899     DOI： 10.1111/j.1440-1843.2006.00937_1.x

Source DB:  PubMed          Journal:  Respirology        ISSN： 1323-7799            Impact factor:   6.424


× No keyword cloud information.
  25 in total

1.  Usefulness of the Legionella Score for differentiating from COVID-19 pneumonia to legionella pneumonia.

Authors:  Naoyuki Miyashita; Futoshi Higa; Yosuke Aoki; Toshiaki Kikuchi; Masafumi Seki; Kazuhiro Tateda; Nobuko Maki; Kazuhiro Uchino; Hiroshi Kiyota; Akira Watanabe
Journal:  J Infect Chemother       Date:  2022-07-08       Impact factor: 2.065

2.  Changes in diagnostic usefulness of the JRS scoring system in COVID-19 pneumonia by SARS-CoV-2 vaccination.

Authors:  Naoyuki Miyashita; Yasushi Nakamori; Makoto Ogata; Naoki Fukuda; Akihisa Yamura; Yoshihisa Ishiura; Shosaku Nomura
Journal:  J Infect Chemother       Date:  2022-06-16       Impact factor: 2.065

3.  Macrolide-resistant Mycoplasma pneumoniae pneumonia in adolescents and adults: clinical findings, drug susceptibility, and therapeutic efficacy.

Authors:  Naoyuki Miyashita; Hiroto Akaike; Hideto Teranishi; Kazunobu Ouchi; Niro Okimoto
Journal:  Antimicrob Agents Chemother       Date:  2013-07-29       Impact factor: 5.191

Review 4.  Antibiotics for community-acquired pneumonia in adult outpatients.

Authors:  Smita Pakhale; Sunita Mulpuru; Theo J M Verheij; Michael M Kochen; Gernot G U Rohde; Lise M Bjerre
Journal:  Cochrane Database Syst Rev       Date:  2014-10-09

5.  JAID/JSC Guidelines for the Treatment of Respiratory Infectious Diseases: The Japanese Association for Infectious Diseases/Japanese Society of Chemotherapy - The JAID/JSC Guide to Clinical Management of Infectious Disease/Guideline-preparing Committee Respiratory Infectious Disease WG.

Authors:  Keiichi Mikasa; Nobuki Aoki; Yosuke Aoki; Shuichi Abe; Satoshi Iwata; Kazunobu Ouchi; Kei Kasahara; Junichi Kadota; Naoki Kishida; Osamu Kobayashi; Hiroshi Sakata; Masahumi Seki; Hiroki Tsukada; Yutaka Tokue; Fukumi Nakamura-Uchiyama; Futoshi Higa; Koichi Maeda; Katsunori Yanagihara; Koichiro Yoshida
Journal:  J Infect Chemother       Date:  2016-06-15       Impact factor: 2.211

6.  Macrolide-resistant Mycoplasma pneumoniae in adolescents with community-acquired pneumonia.

Authors:  Naoyuki Miyashita; Yasuhiro Kawai; Hiroto Akaike; Kazunobu Ouchi; Toshikiyo Hayashi; Takeyuki Kurihara; Niro Okimoto
Journal:  BMC Infect Dis       Date:  2012-05-31       Impact factor: 3.090

7.  Fibroproliferative changes on high-resolution CT in the acute respiratory distress syndrome predict mortality and ventilator dependency: a prospective observational cohort study.

Authors:  Kazuya Ichikado; Hiroyuki Muranaka; Yasuhiro Gushima; Toru Kotani; Habashi M Nader; Kiminori Fujimoto; Takeshi Johkoh; Norihiro Iwamoto; Kodai Kawamura; Junji Nagano; Koichiro Fukuda; Naomi Hirata; Takeshi Yoshinaga; Hidenori Ichiyasu; Shinsuke Tsumura; Hirotsugu Kohrogi; Atsushi Kawaguchi; Masakazu Yoshioka; Tsutomu Sakuma; Moritaka Suga
Journal:  BMJ Open       Date:  2012-03-01       Impact factor: 2.692

Review 8.  Novel aspects on the pathogenesis of Mycoplasma pneumoniae pneumonia and therapeutic implications.

Authors:  Takeshi Saraya; Daisuke Kurai; Kazuhide Nakagaki; Yoshiko Sasaki; Shoichi Niwa; Hiroyuki Tsukagoshi; Hiroki Nunokawa; Kosuke Ohkuma; Naoki Tsujimoto; Susumu Hirao; Hiroo Wada; Haruyuki Ishii; Koh Nakata; Hirokazu Kimura; Kunihisa Kozawa; Hajime Takizawa; Hajime Goto
Journal:  Front Microbiol       Date:  2014-08-11       Impact factor: 5.640

9.  Practice patterns for lower respiratory tract infections in hospital patients with particular focus on bacteriological examinations and injection antibiotics use.

Authors:  Mikio Wada; Takeo Nakayama; Tatsuro Ishizaki; Toshihiko Satoh; Shunya Ikeda
Journal:  Int J Gen Med       Date:  2013-07-18

Review 10.  Viral-bacterial interactions-therapeutic implications.

Authors:  Jane C Deng
Journal:  Influenza Other Respir Viruses       Date:  2013-11       Impact factor: 4.380
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.